W. R. Berkley
WRB
$68.60
-0.84%
W.R. Berkley Corporation is an insurance holding company that underwrites commercial casualty insurance through its subsidiaries, specializing in niche products such as excess and surplus lines, workers' compensation, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses. The company holds a strong market position as a specialist in the property and casualty insurance sector, known for its disciplined underwriting and focus on niche markets, which differentiates it from larger, more diversified insurers. Currently, the investor narrative centers on the company's ability to sustain profitable growth amid a competitive pricing environment and potential reserve development, with recent quarterly results showing steady revenue growth and robust underwriting performance. Attention is also on the impact of interest rates on investment income and the company's capital management strategies, including share repurchases and dividends.…
WRB
W. R. Berkley
$68.60
Related headlines
Investment Opinion: Should I buy WRB Today?
Based on the analysis, WRB is rated a Hold. The thesis is that while the company has solid fundamentals and a defensive profile, the lack of clear catalysts and cautious analyst sentiment limit upside potential. The average analyst target of $69.53 implies a slight downside of 1.4%, and the consensus recommendation is Hold.
Sign up to view all
WRB 12-Month Price Forecast
The AI assessment is neutral, reflecting a balanced risk-reward profile. WRB's profitability is strong, but growth is modest and the stock has underperformed the market. The valuation is fair, but the high PEG ratio suggests limited upside. An upgrade to bullish would require evidence of accelerating growth or a significant margin expansion, while a downgrade to bearish would be triggered by reserve charges or a deteriorating underwriting environment.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on W. R. Berkley's 12-month outlook, with a consensus price target around $69.53 and implied upside of +1.4% versus the current price.
Average Target
$69.53
0 analysts
Implied Upside
+1.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$51 - $83
Analyst target range
WRB is covered by 17 analysts, with a consensus recommendation of 'hold' and a mean recommendation score of 3.39 (where 1 is strong buy and 5 is sell). The average target price is $69.53, which is 1.4% below the current price of $70.51, implying a slight downside. The distribution includes 2 buys, 10 holds, and 5 sells, indicating a cautious sentiment among analysts. The target price range is wide, from a low of $51.00 to a high of $83.00, reflecting significant uncertainty about the company's future performance. The high target of $83.00 assumes strong underwriting results and favorable market conditions, while the low target of $51.00 prices in potential reserve deficiencies or a cyclical downturn. Recent ratings actions have been mixed, with Goldman Sachs upgrading from Neutral to Buy in June 2026, while Wells Fargo downgraded from Equal Weight to Underweight, and Barclays maintained an Underweight rating, suggesting a lack of consensus on the stock's direction.
Bulls vs Bears: WRB Investment Factors
WRB presents a mixed picture: strong profitability improvements and a defensive profile are offset by weak price performance and cautious analyst sentiment. The bull case rests on expanding margins and a reasonable PE, while the bear case highlights underperformance and a high PEG ratio. Currently, the bearish evidence is slightly stronger given the negative relative strength and hold consensus. The key tension is whether WRB's underwriting discipline can continue to drive margin expansion despite a competitive pricing environment, which would justify a re-rating, or if the stock remains range-bound due to limited growth catalysts.
Bullish
- Expanding Profitability: Q1 2026 net margin improved to 13.97% from 11.77% a year ago, while gross margin surged to 47.51% from 22.13%, reflecting strong underwriting performance and lower loss ratios.
- Consistent Revenue Growth: Revenue grew 3.98% YoY in Q1 2026 to $3.69 billion, with a steady upward trend from $3.40 billion in Q3 2024, demonstrating resilience in a competitive market.
- Low Volatility Defensive Profile: With a beta of 0.294, WRB is significantly less volatile than the market, making it a defensive holding that can provide stability during market downturns.
- Strong Free Cash Flow: Free cash flow TTM stands at $3.37 billion, providing ample capacity for dividends, share buybacks, and strategic investments, supporting shareholder returns.
Bearish
- Analyst Consensus is Hold: With a mean recommendation of 3.39 (hold) and an average target price of $69.53, 1.4% below the current price, analysts see limited upside, reflecting cautious sentiment.
- Underperformance vs Market: WRB's 1-year price change of -1.47% contrasts sharply with the S&P 500's +20.37%, and relative strength over 1 year is -21.84%, indicating significant underperformance.
- High PEG Ratio Suggests Overvaluation: The PEG ratio of 7.63x is extremely high, implying that the market is paying a premium for growth that is only expected to be around 7% (forward PE vs trailing PE).
- Mixed Analyst Sentiment: Recent actions include Goldman Sachs upgrade to Buy but Wells Fargo downgrade to Underweight and Barclays maintaining Underweight, reflecting a lack of consensus and potential downside risk.
WRB Technical Analysis
WRB's price trend over the past year has been relatively flat, with a 1-year price change of -1.47%, indicating a range-bound consolidation rather than a clear uptrend or downtrend. The current price of $70.51 sits at approximately 89% of the 52-week range (between $62.87 low and $78.96 high), suggesting the stock is trading near the upper end of its range, which can imply positive momentum but also potential overextension. The stock's beta of 0.294 indicates it is significantly less volatile than the broader market, making it a defensive holding, but this also means it may underperform in strong bull markets.
Beta
0.29
0.29x market volatility
Max Drawdown
-19.0%
Largest decline past year
52-Week Range
$63-$79
Price range past year
Annual Return
-5.4%
Cumulative gain past year
| Period | WRB Return | S&P 500 |
|---|---|---|
| 1m | -5.2% | +2.5% |
| 3m | +1.6% | +2.7% |
| 6m | -3.5% | +11.1% |
| 1y | -5.4% | +20.5% |
| ytd | -1.1% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
WRB Fundamental Analysis
WRB's revenue has shown steady growth, with the most recent quarter (Q1 2026) reporting revenue of $3.69 billion, a 3.98% increase year-over-year. Over the past five quarters, revenue has grown from $3.40 billion in Q3 2024 to $3.69 billion in Q1 2026, reflecting a consistent upward trajectory, though growth has moderated from earlier double-digit rates. The company's net income for Q1 2026 was $515.2 million, with an EPS of $1.31, and the net margin improved to 13.97% from 11.77% in the year-ago quarter, indicating expanding profitability. Gross margin for Q1 2026 was 47.51%, a significant increase from 22.13% in Q1 2025, driven by improved underwriting performance and lower loss ratios.
Quarterly Revenue
$3.7B
2026-03
Revenue YoY Growth
+4.0%
YoY Comparison
Gross Margin
47.5%
Latest Quarter
Free Cash Flow
$3.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is WRB Overvalued?
Given WRB's positive net income, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 15.65x, while the forward PE is 14.60x, indicating that the market expects earnings growth of approximately 7% over the next year. The gap between trailing and forward PE suggests a modest growth expectation, which is reasonable given the company's stable but not explosive growth profile. Compared to the industry average PE of 18x for property and casualty insurers, WRB trades at a discount of about 13%, which may be justified by its lower growth rate relative to some peers. Historically, WRB's PE has ranged from 7.8x to 26.5x over the past five years, with the current 15.65x sitting near the middle of that range, suggesting the stock is fairly valued relative to its own history.
PE
15.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 10x~18x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include a debt-to-equity ratio of 0.29, which is moderate, but the company's reliance on investment income and underwriting results can be volatile. The net margin improved to 13.97% in Q1 2026, but this is subject to claims and reserve development; a significant reserve charge could erode profitability. The payout ratio of 39.35% indicates a sustainable dividend, but free cash flow of $3.37 billion could be impacted by adverse underwriting cycles.
FAQ
The key risks include reserve deficiencies, which could lead to significant earnings charges; competitive pricing pressure in niche markets, which could compress margins; and a cyclical downturn in commercial insurance, which could reduce demand. Additionally, the stock's underperformance relative to the market (1-year relative strength of -21.84%) suggests sector rotation risk. The low analyst target of $51.00 highlights the potential for a 27.7% downside in a severe scenario. The most severe risk is a reserve charge, which could erode investor confidence and lead to multiple compression.
The 12-month forecast is range-bound, with a base case probability of 50% for a target range of $65-$72, aligning with the average analyst target of $69.53. The bull case (25% probability) targets $75-$83, driven by stronger underwriting results, while the bear case (25% probability) targets $51-$62, reflecting potential reserve issues. The most likely scenario is the base case, assuming revenue growth of 3-5% and stable margins. Investors should monitor quarterly results for any deviation from this outlook.
WRB's trailing PE of 15.65x is 13% below the industry average of 18x, suggesting it is undervalued relative to peers. However, the PEG ratio of 7.63x is extremely high, indicating that the market is paying a premium for its limited growth prospects. Historically, the PE has ranged from 7.8x to 26.5x, and the current level is near the middle, suggesting fair value. The market is pricing in modest growth of about 7% (implied by the forward PE of 14.60x), which is reasonable given the company's stable but not explosive growth.
WRB is a reasonable buy for income-focused investors seeking a defensive holding with a 2.52% dividend yield and low volatility (beta 0.294). However, the average analyst target of $69.53 is 1.4% below the current price, and the consensus is Hold, suggesting limited upside. The stock is fairly valued at a PE of 15.65x, but the high PEG ratio of 7.63x indicates that growth expectations are low. It could be a good buy if the price dips below $65, offering a margin of safety, but for growth-oriented investors, there are better opportunities.
WRB is better suited for long-term investment due to its low beta (0.294), stable earnings, and dividend yield of 2.52%. The stock has a history of consistent profitability and is likely to provide steady returns over time, though it may underperform in strong bull markets. Short-term trading is possible given the range-bound price action, but the low volatility limits profit potential. A minimum holding period of 3-5 years is recommended to capture the benefits of compounding dividends and potential valuation re-rating.